• News
  • North America

ODAIA Raises US$15 Million Series C

Publicis Health Media anchors the round and signs a commercial deal

11/19/2026
•Ali Abounasr El Alaoui
Back to News

ODAIA has raised US$15 million (C$21 million) in Series C funding. Monograph Capital led the round. Publicis Health Media (PHM) provided an anchor investment and signed a commercial agreement.


Investor backing

The round included returning investors from ODAIA's Series A and B rounds. BDC Capital, Flint Capital, Innospark Ventures, Graphite Ventures, Threshold Ventures, and Wittington Ventures participated. The deal makes PHM ODAIA's exclusive US agency partner.

Company background

ODAIA was founded out of the University of Toronto in 2018. The company is headquartered in Toronto and has an office in Boston. It supplies predictive commercial intelligence to pharmaceutical and life sciences companies.

What the platform does

The platform helps marketing and sales teams identify physicians whose patients may need a therapy. It prioritizes outreach across digital and field channels. Users can access the reasoning behind each recommendation.


ODAIA will use the capital to go deeper with existing enterprise customers. The PHM agreement is expected to bring its platform to more of the industry faster. PHM also plans to integrate ODAIA's platform into the health, pharma, biotech, and wellness companies it supports.